CDK4 IVS4-nt40 AA genotype and obesity-associated tumors/cancer in Italians – a case-control study
Tóm tắt
Cell cycle checkpoint regulation is crucial for prevention of tumor in mammalian cells. Cyclin-dependant kinase 4 (CDK4) is important in cell cycle regulation, as it controls the G1-S phase of the cell cycle. CDK4 has potential mitogenic properties through phosphorylation of target proteins. We aimed at identifying a role of CDK4 IVS4-nt40 G→A gene variant in benign and/or malignant tumors and in obesity-associated benign and/or malignant tumors in an Italian adult subject dataset. We recruited 263 unrelated Italian subjects: 106 subjects had at least one benign tumor and 46 subjects had at least one malignant tumor, while 116 subjects had at least two tumors and/or cancers. We collected BMI data for 90% of them: 186 subjects had a BMI≥30 Kg/m2 and 52 subjects had a BMI ≥ 30 Kg/m2. We performed statistical power calculations in our datasets. DNA samples were directly sequenced with specific primers for the CDK4 IVS4-nt40 G→A variant. Genotype association tests with disease were performed. In our study, no significant association of the CDK4 IVS4-nt40 AA genotype with cancer and/or tumors/cancer are/is detected. However, the CDK4 IVS4-nt40 AA genotype is significantly associated with cancer and tumors/cancer in obese patients. This finding is interesting since obesity is a risk factor for tumors and cancer. This study should prompt further work aiming at establishing the role of CDK4 in contributing to tumor/cancer genetic risk predisposition, as well as its role as a potentially effective therapeutic target gene for obesity-associated tumor/cancer management.
Tài liệu tham khảo
Ford HL, Pardee AB: Cancer and the cell cycle. J Cell Biochem. 1999, 166-72. Suppl 32–33
Swenne I: The role of glucose in the in vitro regulation of cell cycle kinetics and proliferation of fetal pancreatic B-cells.Diabetes1982, 31(9):754-60.
Bockstaele L, Coulonval K, Kooken H, Paternot S, Roger PP: Regulation of CDK4. Cell Div 2006, 1:25
Cozar-Castellano I, Takane KK, Bottino R, Balamurugan AN, Stewart AF: Induction of beta-cell proliferation and retinoblastoma protein phosphorylation in rat and human islets using adenovirus-mediated transfer of cyclin-dependent kinase-4 and cyclin D1. Diabetes2004, 53(1):149-59.
Ye Y, Yang H, Grossman HB, Dinney C, Wu X, Gu J: Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer. Cancer2008, 112(11):2467-74
van Tilburg JH, Sandkuijl LA, Franke L, Strengman E, Pearson PL, van Haeften TW, Wijmenga C: Genome-wide screen in obese pedigrees with type 2 diabetes mellitus from a defined Dutch population. Eur J Clin Invest2003, 33(12):1070-4
Reis RM, Konu-Lebleblicioglu D, Lopes JM, Kleihues P, Ohgaki H:Genetic profile of gliosarcomas. Am J Pathol2000,156(2):425-32.
Rummel MJ, de Vos S, Hoelzer D, Koeffler HP, Hofmann WK:Altered apoptosis pathways in mantle cell lymphoma. LeukLymphoma2004, 45(1):49-54
Nadal A, Jares P, Pinyol M, Conde L, Romeu C, Fernandez PL, Campo E, Cardesa A: Association of CDK4 and CCND1 mRNA overexpression in laryngeal squamous cell carcinomas occurs without CDK4 amplification. Virchows Arch2007, 450(2):161-7
Micheli A, Francisci S, Krogh V, Rossi AG, Crosignani P: Cancer prevalence in Italian cancer registry areas: the ITAPREVAL study. ITAPREVAL Working Group. Tumori1999, 85(5):309-69
Boru C, Silecchia G, Pecchia A, Iacobellis G, Greco F, Rizzello M, Basso N: Prevalence of cancer in Italian obese patients referred for bariatric surgery. Obes Surg2005, 15(8):1171-6
Matsushime H, Roussel MF, Ashmun RA, Sherr CJ: Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell1991, 65(4):701-13
Rane SG, Dubus P, Mettus RV, Galbreath EJ, Boden G, Reddy EP, Barbacid M: Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet1999, 22(1):44-52
Omata F, Brown WR, Tokuda Y, Takahashi O, Fukui T, Ueno F, Mine T: Modifiable risk factors for colorectal neoplasms and hyperplastic polyps. Intern Med2009, 48(3):123-8
Coyle YM: Lifestyle, genes, and cancer. Methods Mol Biol2009,472:25-56
Jordan SJ, Green AC, Whiteman DC, Webb PM: Risk factors for benign serous and mucinous epithelial ovarian tumors.Obstet Gynecol2007, 109(3):647-54.